WCN26-3120 Impact of Extended-hours Hemodialysis on Erythropoietin Resistance and Clinical Outcomes

Read full text Summarise with VIRAT
Authors: Takumi Yamada, Nobuhiro Nishibori, Masaki Okazaki, Takahiro Imaizumi, Hirotake Kasuga, Fumika Kaneda, Shoichi Maruyama
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Anemia management is a critical component of care in maintenance dialysis patients, with erythropoiesis-stimulating agents (ESAs) widely used as a mainstay therapy. However, responsiveness to ESAs varies among individuals, and elevated erythropoietin resistance index (ERI), a key indicator of treatment efficacy, has been reported to be associated with increased mortality when. Several studies suggest that extended-hours hemodialysis (HD) contributed to lower ERI values and improved survival outcomes compared to conventional HD, though the underlying mechanisms remain unclear.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Dialysis and Renal Disease Management Hemoglobinopathies and Related Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105206–105206
Publication date
25 March 2026
Language
EN